Clinical trial
The Efficacy and Safety of Dabigatran Etexilate and Different Intensity Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation
NCT02646267 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Dabigatran Etexilate and Different Intensity Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2016
- Completion date
- August 31, 2018
- Enrollment
- 210 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.